Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

Journal: Nature Communications

Published: 2018-09-11

DOI: 10.1038/s41467-018-06119-y

Affiliations: 6

Authors: 12

Go to article
Institutions FC
Institute of Medical Virology (IMV), UZH, Switzerland 0.50
Department of Microbiology and Molecular Medicine, UNIGE, Switzerland 0.17
Functional Genomics Center Zurich (FGCZ), Switzerland 0.17
SIB Bioinformatics Core Facility (BCF), Switzerland 0.08
Institute of Virology and Immunology (IVI), Switzerland 0.04
Department of Infectious Diseases and Pathobiology (DIP), UniBE, Switzerland 0.04